Hemoglobin Disorders

This is a group of inherited blood disorders. They affect the hemoglobin, which is the protein in your red blood cells that carries oxygen. These disorders can cause different symptoms depending on the specific type.

Condition

What people with Hemoglobin Disorders report

Every report comes from a Lived member, sent anonymously.

Have you tried Blood transfusion therapy for Hemoglobin Disorders?

NameHow it went

About Hemoglobin Disorders

What It Is

Hemoglobin disorders, also called hemoglobinopathies, are inherited conditions that affect hemoglobin, the protein inside red blood cells that carries oxygen around the body. In some, the body makes too little of one part of normal hemoglobin; in others, it makes an abnormal form. Either way, red blood cells break down early or carry oxygen poorly, which leads to anemia, a shortage of healthy red blood cells that can cause tiredness, weakness and shortness of breath. The two main groups are thalassemia and sickle cell disease. In thalassemia, the body makes too little of one of hemoglobin's two protein chains (alpha or beta), so red cells are fewer and often smaller than usual. In sickle cell disease, an abnormal hemoglobin called hemoglobin S makes red cells stiff and crescent shaped. These cells break apart easily and can block small blood vessels, causing sudden episodes of severe pain and, over time, damage to organs. Severity ranges widely. Many people carry one altered gene, called a trait, and have no symptoms or only mild anemia. Others have a serious lifelong condition that needs regular care from early childhood.

Causes & Risk Factors

Hemoglobin disorders are caused by changes in the genes that hold the instructions for making hemoglobin. They are present from birth. Most follow a recessive pattern. A person with one altered gene and one typical gene is a carrier, described as having sickle cell trait or thalassemia trait. Carriers usually have no symptoms, and a trait does not turn into the disease, but they can pass the gene to their children. When both parents are carriers, each pregnancy has a 1 in 4 chance that the child inherits an altered gene from each parent and has the disease. Some people inherit two different altered genes, such as hemoglobin S from one parent and hemoglobin C or a beta thalassemia gene from the other; these combinations are also forms of sickle cell disease. These conditions are most common in families with roots in Africa, the Mediterranean, the Middle East and South Asia, and sickle cell disease also affects some people of Hispanic background. In the United States, about 1 in 13 Black babies is born with sickle cell trait. In sickle cell disease, some situations can set off a pain crisis or other complications, including dehydration, extreme heat or cold, sudden temperature changes and stress. These are triggers for episodes, not causes of the condition.

How It's Diagnosed

Every US state screens newborns for sickle cell disease using a few drops of blood from a heel prick. The screen also shows whether a baby carries sickle cell trait, and more serious forms of thalassemia are often found this way too. If a result is abnormal, a follow-up team contacts the family and repeats the testing to confirm it. Older children and adults are usually tested because of anemia on a routine blood count, symptoms, or a family history. A complete blood count (CBC) measures hemoglobin and red blood cells; in thalassemia the red cells are often smaller than usual. Special hemoglobin tests, such as electrophoresis or chromatography, separate the types of hemoglobin in the blood and measure how much of each is present. That pattern distinguishes a trait from disease and identifies the specific disorder. Genetic testing can settle the exact type when blood tests are unclear. Testing also matters around pregnancy. A blood test can tell prospective parents whether they carry a hemoglobin gene, and a genetic counselor can explain what the results mean for their children. When both partners are carriers, the pregnancy can be tested early, from about 10 weeks with a sample from the placenta, or later with a sample of the amniotic fluid. This shows whether the baby is affected, but it cannot predict how severe the condition will be.

Treatment Options

Treatment depends on the specific disorder and how severe it is. People with sickle cell trait or thalassemia trait usually need none. People with a serious form do best with care led by a hematologist, a doctor who specializes in blood disorders. For sickle cell disease, hydroxyurea is the main daily medicine. Taken by mouth and often started in infancy, from about 9 months, it reduces sickling and lowers the number of pain crises, episodes of acute chest syndrome (a serious lung complication), transfusions and hospital stays. It needs regular blood count checks because it can lower white cell and platelet counts, and it should not be taken during pregnancy. Young children take daily penicillin to prevent serious bloodstream infections, and vaccines are especially important. Pain is handled with a plan agreed in advance, from fluids, heat and over-the-counter pain relievers at home to stronger medicines in a clinic or hospital. Transfusions treat severe complications and, given regularly, help prevent stroke in children whose transcranial ultrasound (a scan of blood flow in the brain) shows a high risk. For thalassemia, mild forms often need no treatment, while moderate forms may need occasional transfusions during an infection, pregnancy or surgery. Beta thalassemia major usually requires transfusions every 3 to 4 weeks for life. For adults who need regular transfusions, luspatercept (Reblozyl), an injection that helps the body make red cells, can reduce how many transfusions are needed. Removing the spleen is sometimes considered to ease anemia, but it raises the risk of serious infection. Regular transfusions bring in more iron than the body can get rid of, and the excess builds up in the heart, liver and hormone glands. Iron chelation therapy, medicine that binds the extra iron so the body can remove it, is a central part of long-term care for anyone who is transfused often. A stem cell (bone marrow) transplant from a well-matched donor, usually a close relative, can cure both conditions. In sickle cell disease it succeeds in about 90 percent of children with a matched relative donor, but it carries serious and sometimes fatal risks, including graft-versus-host disease (donor immune cells attacking the recipient's tissues), and it is riskier in adults. Gene therapies, which modify a person's own blood-forming stem cells, offer another one-time option for selected people, including those without a matched donor: Casgevy for severe sickle cell disease or transfusion-dependent beta thalassemia, Lyfgenia for sickle cell disease, and Zynteglo for beta thalassemia. Both transplant and gene therapy require chemotherapy beforehand, which can cause infertility (fertility preservation can be discussed first), weeks in a specialized hospital and high cost. Blood cancer has occurred after Lyfgenia, so long-term monitoring is part of the commitment.

What to Expect

The outlook depends on the type. Carriers generally live normal lives with a normal lifespan. Sickle cell trait rarely causes problems, mostly when the body is under unusual strain, such as severe dehydration or intense activity at high altitude, and some people with the trait develop kidney problems. Sickle cell disease is lifelong and varies from person to person and over time. Pain crises can come without warning, and over the years the disease can damage organs. Most people see their care team every 3 to 12 months, take daily medicines, keep up with vaccines and learn to avoid triggers such as dehydration and sudden cold. Parents of young children are often taught to feel the child's spleen daily, because sudden enlargement can signal a dangerous drop in red cells. Many people with sickle cell disease work, study and live full lives, although the illness can disrupt school and work. People also report that their pain is not always taken seriously in health care settings, so a written pain plan and a consistent care team make a real difference. For thalassemia that needs regular transfusions, life is organized around transfusion visits every few weeks, chelation and monitoring. Typical checks include iron levels about every 3 months, liver tests every 6 months, yearly hormone and infection screening, and periodic heart and liver MRI scans to measure stored iron. Children are followed for growth and puberty. Survival and quality of life have improved considerably as transfusions have become safer and chelation easier to take. Planning the move from pediatric to adult care ahead of time helps avoid gaps. Anyone with a hemoglobin disorder who is thinking about pregnancy should talk with the care team early, since medicines, chelation and transfusion plans may need to change.

When to Seek Help

Ask about testing if you have unexplained anemia, a family history of a hemoglobin disorder, or are planning a pregnancy and do not know whether you carry a hemoglobin gene. If a newborn screen is abnormal, arrange the follow-up testing and a hematology visit promptly. With thalassemia, tell the care team if tiredness or breathlessness is building between transfusions or chelation medicine is causing side effects. If you or your child has sickle cell disease, a fever above 101.3°F (38.5°C) needs medical care and antibiotics right away, because serious infections can progress quickly. The same applies to anyone whose spleen has been removed. Call the care team right away if a child's spleen feels larger than usual, and seek emergency care if it comes with the signs of a sudden drop in red cells listed below. For pain you cannot control at home, go to a sickle cell day hospital or an emergency department. In sickle cell disease, seek emergency care for chest pain, cough or shortness of breath, which can signal acute chest syndrome; for extreme tiredness, dizziness or an irregular heartbeat, which can signal a sudden, dangerous drop in red cells; and for an erection lasting 4 hours or more. Call 911 for signs of a stroke, such as sudden weakness or numbness on one side of the body, confusion, or trouble speaking, seeing or walking.

Questions to Ask Your Doctor

  1. 1.Exactly which hemoglobin disorder is this, and how severe is it likely to be?
  2. 2.Should my partner or other family members be tested, and would genetic counseling help us?
  3. 3.Which treatments make sense now, and is a transplant or gene therapy worth considering?
  4. 4.If regular transfusions are needed, how will iron levels be monitored and controlled?
  5. 5.What is our plan for fever, pain or other urgent symptoms, and where should we go?

Last reviewed • Oct 2026

Educational content, not medical advice.